18.03.2016 Views

Research Report and Overview on Molecular Diagnostics Market, 2016-2026

Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Molecular diagnostics are used to diagnose disease and risk involved. Molecular Diagnostics helps to decide the therapies are suitable for individual patients. The new advanced technologies has qualified the instruments in providing accurate results. This ability of the diagnostic tool resulted in increased rate of acceptance of the molecular diagnostics. The concept of personalized medicine has emerged out of molecular diagnostics.

Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Molecular diagnostics are used to diagnose disease and risk involved. Molecular Diagnostics helps to decide the therapies are suitable for individual patients. The new advanced technologies has qualified the instruments in providing accurate results. This ability of the diagnostic tool resulted in increased rate of acceptance of the molecular diagnostics. The concept of personalized medicine has emerged out of molecular diagnostics.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Molecular</strong> <strong>Diagnostics</strong><br />

<strong>Market</strong><br />

Share, Global Trends,<br />

Analysis, <str<strong>on</strong>g>Research</str<strong>on</strong>g>, <str<strong>on</strong>g>Report</str<strong>on</strong>g>,<br />

Opportunities,<br />

Segmentati<strong>on</strong> <str<strong>on</strong>g>and</str<strong>on</strong>g> Forecast,<br />

<strong>2016</strong><br />

Future <strong>Market</strong> Insights<br />

www.futuremarketinsights.com<br />

sales@futuremarketinsights.com


Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <str<strong>on</strong>g>and</str<strong>on</strong>g> c<strong>on</strong>sulting<br />

services. We deliver a complete packaged soluti<strong>on</strong>, which combines current market intelligence, statistical anecdotes,<br />

technology inputs, valuable growth insights, aerial view of the competitive framework, <str<strong>on</strong>g>and</str<strong>on</strong>g> future market trends.<br />

We provide research services at a global as well as regi<strong>on</strong>al level; key regi<strong>on</strong>s include GCC, ASEAN, <str<strong>on</strong>g>and</str<strong>on</strong>g> BRIC.<br />

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <str<strong>on</strong>g>and</str<strong>on</strong>g><br />

Retail.<br />

We have a global presence with delivery centers across India specializing in providing global research reports <str<strong>on</strong>g>and</str<strong>on</strong>g> country<br />

research reports. FMI is headquartered out of L<strong>on</strong>d<strong>on</strong>, U.K., with a state-of-the-art delivery center located in Pune, India.<br />

We combine our knowledge <str<strong>on</strong>g>and</str<strong>on</strong>g> learning from every corner of the world to distill it to <strong>on</strong>e thing – the perfect soluti<strong>on</strong> for<br />

our client.<br />

<str<strong>on</strong>g>Research</str<strong>on</strong>g> Capabilities<br />

• Customized <str<strong>on</strong>g>Research</str<strong>on</strong>g><br />

• Syndicated <str<strong>on</strong>g>Research</str<strong>on</strong>g><br />

• Investment <str<strong>on</strong>g>Research</str<strong>on</strong>g><br />

• Social Media <str<strong>on</strong>g>Research</str<strong>on</strong>g><br />

Sector Coverage<br />

• Automotive <str<strong>on</strong>g>and</str<strong>on</strong>g> Transportati<strong>on</strong><br />

• Electr<strong>on</strong>ics, Semic<strong>on</strong>ductor, <str<strong>on</strong>g>and</str<strong>on</strong>g> ICT<br />

• Retail <str<strong>on</strong>g>and</str<strong>on</strong>g> C<strong>on</strong>sumer Products<br />

• Industrial Automati<strong>on</strong> <str<strong>on</strong>g>and</str<strong>on</strong>g> Equipment<br />

• Chemicals & Materials<br />

• Food <str<strong>on</strong>g>and</str<strong>on</strong>g> Beverages<br />

• Services <str<strong>on</strong>g>and</str<strong>on</strong>g> Utilities<br />

• Energy, Mining, Oil, <str<strong>on</strong>g>and</str<strong>on</strong>g> Gas<br />

Customized<br />

<str<strong>on</strong>g>Research</str<strong>on</strong>g><br />

Syndicated<br />

<str<strong>on</strong>g>Research</str<strong>on</strong>g><br />

Investment<br />

<str<strong>on</strong>g>Research</str<strong>on</strong>g><br />

Social Media<br />

<str<strong>on</strong>g>Research</str<strong>on</strong>g><br />

Subscripti<strong>on</strong> Informati<strong>on</strong><br />

For detailed subscripti<strong>on</strong> informati<strong>on</strong> please c<strong>on</strong>tact<br />

Hari. T (Sr. Manager - Global Business Development)<br />

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />

Email: hari.t@futuremarketinsights.com


<str<strong>on</strong>g>Report</str<strong>on</strong>g> Descripti<strong>on</strong><br />

<strong>Molecular</strong> diagnostics is a method of analyzing <str<strong>on</strong>g>and</str<strong>on</strong>g> identifying the biological markers in<br />

the genome <str<strong>on</strong>g>and</str<strong>on</strong>g> proteome in order to identify gene expressi<strong>on</strong> by applying molecular<br />

biology. <strong>Molecular</strong> diagnostics are used to diagnose disease <str<strong>on</strong>g>and</str<strong>on</strong>g> risk involved. <strong>Molecular</strong><br />

<strong>Diagnostics</strong> helps to decide the therapies are suitable for individual patients. The new<br />

advanced technologies has qualified the instruments in providing accurate results. This<br />

ability of the diagnostic tool resulted in increased rate of acceptance of the molecular<br />

diagnostics. The c<strong>on</strong>cept of pers<strong>on</strong>alized medicine has emerged out of molecular<br />

diagnostics.<br />

<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>: Drivers & Restraints<br />

The factors driving molecular diagnostic market are increase in dem<str<strong>on</strong>g>and</str<strong>on</strong>g> for care facilities,<br />

favorable regulatory policies which aims at promoting the care diagnosis, acceptance of<br />

pers<strong>on</strong>alized medicine, development in biomarkers, advancements in proteomics,<br />

increasing awareness of the diagnostic procedures. However rising cost of molecular<br />

diagnostics, obligati<strong>on</strong> of skilled labors to h<str<strong>on</strong>g>and</str<strong>on</strong>g>le the complexity of instruments are the<br />

factors restraining the growth of molecular diagnostics market.<br />

Request free sample <str<strong>on</strong>g>Report</str<strong>on</strong>g>: http://www.futuremarketinsights.com/reports/sample/repgb-1262<br />

<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>: Segmentati<strong>on</strong><br />

<strong>Molecular</strong> diagnostic market is classified <strong>on</strong> the basis of product, technology, applicati<strong>on</strong>,<br />

end use <str<strong>on</strong>g>and</str<strong>on</strong>g> geography.


<str<strong>on</strong>g>Report</str<strong>on</strong>g> Descripti<strong>on</strong><br />

Based <strong>on</strong> product, the global molecular diagnostic market is segmented into the<br />

following:<br />

• Instruments<br />

• Reagents<br />

• Others (service <str<strong>on</strong>g>and</str<strong>on</strong>g> software)<br />

Based <strong>on</strong> technology, the global molecular diagnostic market is segmented into the<br />

following:<br />

• DNA sequencing<br />

• Polymerase chain reacti<strong>on</strong><br />

• Isothermal Nucleic Acid Amplificati<strong>on</strong> Technology<br />

• Transcripti<strong>on</strong> Mediated Amplificati<strong>on</strong> (TMA)<br />

• In situ hybridizati<strong>on</strong><br />

• Sequencing<br />

• Microarrays<br />

• Mass spectrometry<br />

• DNA sequencing


<str<strong>on</strong>g>Report</str<strong>on</strong>g> Descripti<strong>on</strong><br />

• Others (southern blotting, northern blotting, electrophoresis)<br />

Based <strong>on</strong> applicati<strong>on</strong>, the global molecular diagnostic market is segmented into<br />

following:<br />

• Cancer<br />

• Pharmacogenomics<br />

• Genetic testing<br />

• Infectious disease<br />

• Prenatal<br />

• Neurological disease<br />

• Cardiovascular disease<br />

Based <strong>on</strong> end use, the global molecular diagnostic market is segmented into following:<br />

• Diagnostic laboratories<br />

• Hospitals<br />

• Others( nursing home, blood banks, point of care)<br />

<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>: <str<strong>on</strong>g>Overview</str<strong>on</strong>g>


<str<strong>on</strong>g>Report</str<strong>on</strong>g> Descripti<strong>on</strong><br />

The awareness of diagnosis is giving rise to the trend of self-care management. The early<br />

diagnosis of disease or disorder helps the patient in getting better treatment <str<strong>on</strong>g>and</str<strong>on</strong>g> cure.<br />

Infectious disease <str<strong>on</strong>g>and</str<strong>on</strong>g> Oncology is estimated to be the fastest growing applicati<strong>on</strong> owing<br />

to the increased prevalence of cancer <str<strong>on</strong>g>and</str<strong>on</strong>g> dem<str<strong>on</strong>g>and</str<strong>on</strong>g> for early diagnosis. The introducti<strong>on</strong><br />

to specific biomarkers for the treatment has a positive impact over the molecular<br />

diagnosis market. However maximum use of reagents is estimated owing to their<br />

accurate results. Comm<strong>on</strong>ly used reagents are salts, formamide, sodium dodecyl sulfate<br />

<str<strong>on</strong>g>and</str<strong>on</strong>g> dextran sulphate heparin. Growing awareness about the prenatal genetic testing for<br />

early detecti<strong>on</strong> of chromosomal abnormalities during pregnancy has enhanced the use of<br />

molecular diagnostics.<br />

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1262<br />

<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>: Regi<strong>on</strong>-wise Outlook<br />

Depending <strong>on</strong> geographic regi<strong>on</strong>s, the Global <strong>Molecular</strong> <strong>Diagnostics</strong> market is segmented<br />

into seven key regi<strong>on</strong>s: North America, South America, Eastern Europe, Western Europe,<br />

Asia Pacific Excluding Japan, Japan, <str<strong>on</strong>g>and</str<strong>on</strong>g> Middle East & Africa. North America is estimated<br />

to be the largest player in molecular diagnostic market owing to the technological<br />

advancements <str<strong>on</strong>g>and</str<strong>on</strong>g> innovati<strong>on</strong>s, increase in R&D investments by large pharmaceutical<br />

<str<strong>on</strong>g>and</str<strong>on</strong>g> biotechnological industries <str<strong>on</strong>g>and</str<strong>on</strong>g> dem<str<strong>on</strong>g>and</str<strong>on</strong>g> for early diagnosis. Asia Pacific is estimated<br />

in rising molecular diagnostic market due to increase in the prevalence of diseases such<br />

as cardiovascular diseases, infectious diseases <str<strong>on</strong>g>and</str<strong>on</strong>g> large populati<strong>on</strong> suffering from<br />

diabetes.


<str<strong>on</strong>g>Report</str<strong>on</strong>g> Descripti<strong>on</strong><br />

<strong>Molecular</strong> diagnostics <strong>Market</strong>: Key Players<br />

Some of the key players identified in the molecular diagnostic market are Abbott<br />

laboratories, Bect<strong>on</strong> Dickins<strong>on</strong>, Novartis, Roche <strong>Diagnostics</strong>, Johns<strong>on</strong> <str<strong>on</strong>g>and</str<strong>on</strong>g> Johns<strong>on</strong>, Bio-<br />

Rad Laboratories, bioMerieux, Danaher Corporati<strong>on</strong>, Qiagen N.V, Siemens Healthcare,<br />

Cepheid, Hologic, Inc,.<br />

Browse full report: http://www.futuremarketinsights.com/reports/moleculardiagnostics-market


Thank You!<br />

To know more about us, please visit our website:<br />

www.futuremarketinsights.com<br />

For sales queries or new topics email us <strong>on</strong>:<br />

sales@futuremarketinsights.com<br />

For other queries c<strong>on</strong>tact: Mr. Sudip Saha<br />

Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />

Valley Cottage, NY 10989, United States<br />

T: +1-347-918-3531 | D: +1-845-579-5705

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!